Tyra Biosciences, Inc. (TYRA) delivered a return of 198.11% over the past year. Since TYRA does not currently pay dividends, the total return equals the price-only return.

A $10,000 investment in Tyra Biosciences, Inc. one year ago would be worth $29,811 today, representing a gain of $19,811.

Tyra Biosciences, Inc. (TYRA) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For TYRA, the total return equals the price-only return.

Yes, Tyra Biosciences, Inc. (TYRA) outperformed the S&P 500 by 173.12 percentage points over the past year. TYRA delivered a total return of 198.11%, compared to the S&P 500's 24.99%. This 173.12pp alpha means investors in TYRA earned more than a passive S&P 500 index fund.

Tyra Biosciences, Inc. (TYRA) experienced a maximum drawdown of -35.82% over the past year, declining from its peak on 2026-04-02 to its trough on 2026-06-10. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Here are Tyra Biosciences, Inc. (TYRA)'s long-term returns with dividends reinvested. Over 10 years, the total return is 8.9% (0.9% CAGR) — $10,000 would have grown to $10,892. Over 20 years: 8.9% total return (0.4% CAGR) — $10,000 → $10,892. Over 30 years: 8.9% total return (0.3% CAGR) — $10,000 → $10,892. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Tyra Biosciences, Inc.'s best calendar year was 2023 with a total return of 95.9%. Its worst year was 2022 with a total return of -46.1%. This range shows the volatility investors should expect — the difference between the best and worst year is 142.0 percentage points.